期刊文献+

尼曼匹克C1样蛋白1及其与胆囊胆固醇结石形成关系的研究进展 被引量:1

下载PDF
导出
摘要 脂质代谢异常与胆固醇结石病、动脉粥样硬化、冠心病等疾病发生关系密切。尼曼匹克C1样蛋白1(Niemann Pick C1 like 1,NPC1L1)是小肠参与胆固醇摄取的重要蛋白质[1],自其被发现以来,一直是研究和临床关注的热点。本文对NPC1L1蛋白及其基因多态性研究的最新成果作一综述,并对其在相关疾病治疗中的作用作一展望。
作者 吴健 蒋兆彦
出处 《外科理论与实践》 2015年第3期262-265,共4页 Journal of Surgery Concepts & Practice
  • 相关文献

参考文献33

  • 1Altmann SW, Davis HR Jr, Zhu LJ, et al. Niemann-PickCl Like 1 protein is critical for intestinal cholesterol ab-sorption[J]. Science,2004,303(5661): 1201-1204.
  • 2Davies JP, Levy B, Ioannou YA. Evidence for a Nie-mann-pick C (NPC) gene family: identification and cha-racterization of NPC1L1[J]. Genomics,2000,65(2):137-145.
  • 3Ninomiya H. Niemann-Pick Cl-Like 1: A key player inintestinal cholesterol absorption [J]. Yonago Acta Medica,2010,53(2):29-36.
  • 4Wang U, Song BL. Niemann-Pick Cl-Like 1 and choles-terol uptake[J]. Biochim Biophys Acta,2012,1821 (7):964-972.
  • 5Temel RE, Tang W, Ma Y, et al. Hepatic Niemann-PickCl-like 1 regulates biliary cholesterol concentration andis a target of ezetimibe[J]. J Clin Invest,2007,117(7): 1968-1978.
  • 6Ahmed MH, Byrne CD. Potential therapeutic uses forezetimibe beyond lowering LDL-C to decrease cardiovas-cular events[J]. Diabetes Obes Metab,2010,12(11):958-966.
  • 7Davies JP, Scott C,Oishi K,et al. Inactivation ofNPC 1 LI causes multiple lipid transport defects and pro-tects against diet-induced hypercholesterolemia [J]. J BiolChem,2005,280(13):12710-12720.
  • 8Yu L, Bharadwaj S, Brown JM, et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitatesfree cholesterol uptake[J]. J Biol Chem,2006,281(10):6616-6624.
  • 9Davis HR Jr, Zhu LJ, Hoos LM, et al Niemann-Pick Cl Like 1(NPC 1 LI) is the intestinal phytosterol and cholesterol trans-porter and a key modulator of whole-body cholesterol home-ostasis[J]. J Biol Chem,2004,279(32):33586-33592.
  • 10Huang Y, Zheng Y. The probiotic lactobacillus aci-dophilus reduces cholesterol absorption through thedown-regulation of Niemann-Pick Cl-like 1 in Caco-2cells[J]. Br J Nutr,2010,103(4):473-478.

二级参考文献15

  • 1Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data [J]. Lancet, 2006, 367(9524): 1747-1757.
  • 2Wang Q. Molecular genetics of coronary artery disease[J]. Curr Opin Cardiol, 2005, 20(3): 182-188.
  • 3Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids[J]. Nature, 2010, 466(7307): 707-713.
  • 4Chen CW, Hwang JJ, Tsai CT, at al. The g.-762T>C polymorphism of the NPC1L1 gene is common in Chineseand contributes to a higher promoter activity and higher serum cholesterol levels [J]. J Hum Genet, 2009, 54(4): 242-247.
  • 5Kathiresan S, Manning AK, Demissie S, et al. A genomewide association study for blood lipid phenotypes in the Framingham heart study [J]. BMC Med Genet, 2007, 8 Suppl 1: S17.
  • 6Willer C J, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease[J]. Nat Genet, 2008, 40(2): 161-169.
  • 7Ahmann SW, Davis HR Jr, Zhu IJ, et al. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption[J]. Science, 2004, 303(5661): 1201-1204.
  • 8Martin B, Solanas-Barca M, Garcla-Otin AL, et al. An NPC1L1 gene promoter variant is associated with autoso- mal dominant hypercholesterolemia [J]. Nutr Metab Cardiovasc Dis, 2010, 20(4): 236-242.
  • 9Wang LJ, Wang J, Li N, et al. Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers[J]. J Biol Chem, 2011, 286(9): 7397-7408.
  • 10Simon JS, Karnoub MC, Devlin DJ, et al. Sequence variation in NPC1L1 and association with improved EDL- cholesterol lowering in response to ezetimibe treatment[J].Genomies, 2005, 86(6): 648-656.

共引文献1

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部